TAK:NYE-Takeda Pharmaceutical Company Limited

COMMON STOCK | Drug Manufacturers - Specialty & Generic |

Last Closing

USD 17.99

Change

+0.20 (+1.12)%

Market Cap

USD 55.84B

Volume

1.76M

Analyst Target

USD 25.71
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2019-07-15 )

Largest Industry Peers for Drug Manufacturers - Specialty & Generic

Symbol Name Price(Change) Market Cap
ZTS Zoetis Inc

+1.32 (+0.88%)

USD 66.94B
HLN Haleon plc

-0.06 (-0.71%)

USD 37.53B
TEVA Teva Pharma Industries Ltd ADR

N/A

USD 15.97B
RDY Dr. Reddy’s Laboratories Ltd..

-0.57 (-0.80%)

USD 11.85B
CTLT Catalent Inc

-0.08 (-0.14%)

USD 10.04B
ELAN Elanco Animal Health

-0.15 (-1.11%)

USD 6.40B
PRGO Perrigo Company PLC

+0.74 (+2.43%)

USD 4.26B
PBH Prestige Brand Holdings Inc

-1.09 (-1.53%)

USD 3.43B
EVT Eaton Vance Tax Advantaged Div..

+0.01 (+0.04%)

USD 3.26B
BHC Bausch Health Companies Inc

+0.03 (+0.35%)

USD 3.13B

ETFs Containing TAK

1638:TSE 25.17 % 0.00 %

N/A

N/A
1310:TSE 4.71 % 0.00 %

N/A

N/A
1344:TSE 3.32 % 0.00 %

N/A

N/A
JPMV:PA 2.66 % 0.00 %

N/A

N/A
OSXJ:XETRA 2.66 % 0.00 %

N/A

N/A
JPCHBH:SW 1.73 % 0.00 %

N/A

N/A
JPEUBH:SW 1.73 % 0.00 %

N/A

N/A
JPUSBH:SW 1.73 % 0.00 %

N/A

N/A
UEF2:F 1.66 % 0.00 %

N/A

N/A
UEF2:XETRA 1.66 % 0.00 %

N/A

N/A
ADRA 0.00 % 0.30 %

N/A

N/A
HFXJ 0.00 % 0.30 %

N/A

N/A
BSCS Invesco BulletShares 2028.. 0.00 % 0.10 %

-0.04 (0.30%)

USD 1.44B
ZJPN 0.00 % 0.30 %

N/A

N/A
XZMJ:LSE Xtrackers ESG MSCI Japan .. 0.00 % 0.00 %

+0.10 (+0.30%)

USD 1.89B
CBBB:PA 0.00 % 0.00 %

N/A

N/A
LYY4:F Multi Units France - Lyxo.. 0.00 % 0.00 %

+0.20 (+0.30%)

USD 0.53B
XDNE:F db x-trackers JPX-Nikkei .. 0.00 % 0.00 %

+0.18 (+0.30%)

USD 0.04B
XDNY:F Xtrackers MSCI Japan ESG .. 0.00 % 0.00 %

+0.06 (+0.30%)

USD 56.18B
CAB3:XETRA 0.00 % 0.00 %

N/A

N/A
J1GR:XETRA Amundi Index Solutions - .. 0.00 % 0.00 %

+0.48 (+0.30%)

USD 0.17B
JER5:XETRA JPMorgan ETFs Ireland ICA.. 0.00 % 0.00 %

-0.21 (0.30%)

USD 0.12B
JPNH:XETRA Lyxor UCITS Japan Topix D.. 0.00 % 0.00 %

+0.54 (+0.30%)

USD 0.18B
LCUJ:XETRA Lyxor Core MSCI Japan (DR.. 0.00 % 0.00 %

+0.06 (+0.30%)

USD 191.96B
LYY4:XETRA Multi Units France - Lyxo.. 0.00 % 0.00 %

+0.34 (+0.30%)

USD 0.58B
SGAJ:XETRA iShares MSCI Japan ESG Sc.. 0.00 % 0.00 %

+0.02 (+0.30%)

USD 2.13B
SODJ:XETRA iShares MSCI Japan ESG Sc.. 0.00 % 0.00 %

+0.02 (+0.30%)

USD 2.13B
XZMJ:XETRA Xtrackers ESG MSCI Japan .. 0.00 % 0.00 %

+0.11 (+0.30%)

USD 2.01B
1311:TSE Nomura TOPIX Core30 Liste.. 0.00 % 0.00 %

+33.00 (+0.30%)

USD 9.25B
1474:TSE DIAM JPX Nikkei 400 0.00 % 0.00 %

+450.00 (+0.30%)

USD 284.09B
1475:TSE iShares Core TOPIX ETF 0.00 % 0.00 %

+49.00 (+0.30%)

USD 1,877.98B
1481:TSE Listed Index Fund Japanes.. 0.00 % 0.00 %

+94.00 (+0.30%)

USD 4.27B
1483:TSE iShares JPX/S&P CAPEX & H.. 0.00 % 0.00 %

+43.00 (+0.30%)

USD 16.13B
1586:TSE Listed Index Fund TOPIX E.. 0.00 % 0.00 %

+36.00 (+0.30%)

USD 2.72B
1593:TSE MAXIS JPX-Nikkei 400 0.00 % 0.00 %

+410.00 (+0.30%)

USD 835.34B
1651:TSE Daiwa TOPIX High Dividend.. 0.00 % 0.00 %

+29.00 (+0.30%)

USD 45.77B
1585:TSE Daiwa TOPIX Ex-Financials 0.00 % 0.00 %

+29.00 (+0.30%)

USD 4.41B
NADA:XETRA Lyxor Core MSCI Japan (DR.. 0.00 % 0.00 %

+0.23 (+0.30%)

N/A
JPNJPA:SW UBS(Lux)Fund Solutions .. 0.00 % 0.00 %

+0.36 (+0.30%)

USD 115.04B
HJPN:AU BetaShares WisdomTree Jap.. 0.00 % 0.00 %

+0.42 (+0.30%)

USD 0.15B
IJP:AU iShares MSCI Japan ETF (A.. 0.00 % 0.00 %

+0.96 (+0.30%)

USD 0.61B
EMNJ:F iShares IV PLC - iShares .. 0.00 % 0.00 %

+0.02 (+0.30%)

USD 1.90B

Market Performance

  Market Performance vs. Industry/Classification (Drug Manufacturers - Specialty & Generic) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 6.96% 47% F 33% F
Dividend Return N/A N/A N/A N/A F
Total Return 6.96% 47% F 29% F
Trailing 12 Months  
Capital Gain N/A N/A N/A N/A F
Dividend Return N/A N/A N/A N/A F
Total Return N/A N/A N/A N/A F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A F
Dividend Return N/A N/A N/A N/A F
Total Return N/A N/A N/A N/A F
Average Annual (5 Year Horizon)  
Capital Gain N/A N/A N/A N/A F
Dividend Return N/A N/A N/A N/A F
Total Return N/A N/A N/A N/A F
Risk Return Profile  
Volatility (Standard Deviation) N/A N/A N/A N/A F
Risk Adjusted Return N/A N/A N/A N/A F
Market Capitalization 55.84B 100% F 96% N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.